marijuana stocks news

EQUITY ALERT: Rosen Law Firm Reminds Medbox, Inc. Investors of Important Deadline in Class Action — MDBX

 NEW YORK, Feb. 6, 2015 (GLOBE NEWSWIRE) — The Rosen Law Firm, a global investor rights firm, reminds purchasers of Medbox, Inc. common stock (“MDBX”) during the period from November 20, 2013 to December 29, 2014 of the important March 23, 2015 lead plaintiff deadline in the class action lawsuit filed by the firm.

To join the Medbox class action, visit the firm’s website at https://www.rosenlegal.com/cases-468.html, or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free, at 866-767-3653; you may also email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY CHOOSE TO DO NOTHING AT THIS POINT AND REMAIN AN ABSENT CLASS MEMBER.

According to the lawsuit, Medbox overstated the Company’s revenues by recognizing revenue on customer contracts before it had been earned. On December 30, 2014, Medbox announced that its financial statements for: (i) the year ended December 31, 2013, (ii) the third and fourth quarters of 2013, and (iii) the first and second quarters of 2014 can no longer be relied upon, as they are materially inaccurate. This news caused Medbox’s share price to decline, damaging investors.

If you wish to serve as lead plaintiff, you must move the Court no later than March 23, 2015. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation go to https://www.rosenlegal.com/cases-468.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of The Rosen Law Firm, toll-free, at 866-767-3653, or via e-mail at pkim@rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

View photo

.

Contact:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm P.A.
275 Madison Avenue 34th Floor
New York, New York 10016
Tel: (212) 686-1060
Toll Free: 1-866-767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Endexx Corporation (EDXC) Announces Record Revenue for Fiscal Year 2018 Financial Results

CBD Unlimited, Inc. (Formerly Endexx) Announces Record Revenue for Fiscal Year 2018…

 Tetra Bio-Pharma Inc. (TBPMF) Management Provides Regulatory Update of ARDS-003

Tetra Bio-Pharma’s Management Provides Regulatory Update of ARDS-003 for the Potential Prevention…

Charlotte’s Web Holdings, Inc. (CWBHF) Reports 2022 Fourth Quarter And Year-End Financial Results

Charlotte’s Web Reports 2022 Fourth Quarter And Year-End Financial Results (TSX: CWEB)…

$CBIS Provides Guidance on the Company’s New Year and Products, Developments and ‘Initiatives in Action’ for 2015

Cannabis Science (CBIS) Provides Guidance on the Company’s New Year and Products,…